• IRDAI allows Arogya Sanjeevani policy to be sold as group health insurance

    The Insurance Regulatory and Development Authority of India (IRDAI) has now allowed general and standalone health insurers to offer the

    Read More
  • AstraZeneca’s Farxiga Dazzles in Phase III Kidney Disease Trial

    AstraZeneca reported successful results from its Phase III DAPA-CKD clinical trial of Farxiga (dapagliflozin) in end stage kidney disease (ESKD). The trial

    Read More
  • Aarti Drugs revenue rises 34.34% yoy to Rs544.67cr in Q1

    Aarti Drugs Limited on Monday announced the financial results of the quarter ended June 2020. The company recorded consolidated quarterly revenue

    Read More
  • Immunic, Inc. Announces First Patients Enrolled in Investigator-Sponsored Phase 2 Clinical Trial

    Immunic, Inc., a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases,

    Read More
  • Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat

    Drug firm Unichem Laboratories NSE 2.05 % on Wednesday said it has received approval from the US health regulator for

    Read More


error: Content is protected !!